PIERREL

Pierrel is an Italian pharmaceutical company with over 70 years of experience in the oral health industry, its products are marketed in most global markets.

Our legal and operational headquarters are in Capua (CE). Our core business focuses on the registration and commercialization of our dental anesthetics. The production facility was authorized by the EMA (European Medicines Agency) in 1989 and by the FDA (Food and Drug Administration) in 2009 for the aseptic production of injectable drugs.

With over 70 years of experience, Pierrel is one of the leading producers of dental anesthetics marketed under its own brands: Orabloc®, Ubisestin™, Xylestesin™, and Mepivastesin™; authorized by major international drug regulatory agencies and available in most global markets. Our specialization in the dental sector also extends to the research, development, and distribution of medical devices.